These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 28552625)
141. How Can We Improve the Use of Established Therapies in PsA? Nash P J Rheumatol; 2020 Aug; 47(8):1153-1154. PubMed ID: 32739898 [No Abstract] [Full Text] [Related]
142. Real-world data provide insights into PsA treatment patterns. Marzo-Ortega H; Harrison SR Nat Rev Rheumatol; 2023 Aug; 19(8):466-467. PubMed ID: 37059913 [No Abstract] [Full Text] [Related]
143. Current concepts and unmet needs in psoriatic arthritis. Mahmood F; Coates LC; Helliwell PS Clin Rheumatol; 2018 Feb; 37(2):297-305. PubMed ID: 29134513 [TBL] [Abstract][Full Text] [Related]
144. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort. Lubrano E; De Socio A; Perrotta FM J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467 [TBL] [Abstract][Full Text] [Related]
145. Superiority of magnetic resonance imaging over conventional radiography in the early diagnosis of psoriatic arthritis. Hayashi M; Yanaba K; Umezawa Y; Asahina A; Nakagawa H J Dermatol; 2017 Oct; 44(10):e232-e233. PubMed ID: 28556938 [No Abstract] [Full Text] [Related]
146. Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate. Costa L; Lubrano E; Ramonda R; Chimenti MS; Vezzù M; Perrotta FM; Del Puente A; Peluso R; Bottiglieri P; Lorenzin M; Sunzini F; Darda MA; Fiocco U; Perricone R; Punzi L; Scarpa R; Caso F Clin Rheumatol; 2017 Aug; 36(8):1797-1802. PubMed ID: 28589323 [TBL] [Abstract][Full Text] [Related]
147. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers. Cretu D; Gao L; Liang K; Soosaipillai A; Diamandis EP; Chandran V Arthritis Care Res (Hoboken); 2018 Mar; 70(3):454-461. PubMed ID: 28586166 [TBL] [Abstract][Full Text] [Related]
148. The global state of psoriasis disease epidemiology: a workshop report. Griffiths CEM; van der Walt JM; Ashcroft DM; Flohr C; Naldi L; Nijsten T; Augustin M Br J Dermatol; 2017 Jul; 177(1):e4-e7. PubMed ID: 28555722 [TBL] [Abstract][Full Text] [Related]
149. Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients. Garrido-Cumbrera M; Hillmann O; Mahapatra R; Trigos D; Zajc P; Weiss L; Bostynets G; Gossec L; Coates LC Rheumatol Ther; 2017 Dec; 4(2):219-231. PubMed ID: 28600789 [TBL] [Abstract][Full Text] [Related]
150. Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanercept. Gyldenløve M; Zachariae C; Jensen P; Griehsel H; Ståhle M; Skov L J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):e518-e519. PubMed ID: 28557009 [No Abstract] [Full Text] [Related]
151. Nonsteroidal anti-inflammatory drug-induced protein-losing enteropathy: a great masquerade of Crohn's disease. Vinsard DG; Stark ME; Lewis JT; Wang MH Gastrointest Endosc; 2017 Dec; 86(6):1180-1181. PubMed ID: 28554654 [No Abstract] [Full Text] [Related]
152. The pathogenesis of psoriatic arthritis. Veale DJ; Fearon U Lancet; 2018 Jun; 391(10136):2273-2284. PubMed ID: 29893226 [TBL] [Abstract][Full Text] [Related]
153. The association between psoriasis and coeliac disease. Egeberg A; Griffiths CEM; Mallbris L; Gislason GH; Skov L Br J Dermatol; 2017 Dec; 177(6):e329-e330. PubMed ID: 28555725 [No Abstract] [Full Text] [Related]
154. Influence of TNF-alpha inhibitors and fumaric acid esters on male fertility in psoriasis patients. Heppt F; Colsman A; Maronna A; Uslu U; Heppt MV; Kiesewetter F; Sticherling M J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1860-1866. PubMed ID: 28557008 [TBL] [Abstract][Full Text] [Related]
155. Psoriasis in patients with mycosis fungoides: a clinicopathological study of 25 patients. Nikolaou V; Marinos L; Moustou E; Papadavid E; Economidi A; Christofidou E; Gerochristou M; Tasidou A; Economaki E; Stratigos A; Antoniou C J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1848-1852. PubMed ID: 28557175 [TBL] [Abstract][Full Text] [Related]
156. Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report. Jones N; Carvalho M; Branvold-Herr A Int J Pharm Compd; 2017; 21(3):205-211. PubMed ID: 28557781 [TBL] [Abstract][Full Text] [Related]
157. Biologics for psoriasis : maintenance treatment and true disease modification. van de Kerkhof PC J Dermatolog Treat; 2017 Jun; 28(4):281. PubMed ID: 28566054 [No Abstract] [Full Text] [Related]
158. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches. Rajitha P; Biswas R; Sabitha M; Jayakumar R Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554 [TBL] [Abstract][Full Text] [Related]
159. Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial. Sticherling M; Mrowietz U; Augustin M; Thaçi D; Melzer N; Hentschke C; Kneidl J; Sieder C; Reich K Br J Dermatol; 2017 Oct; 177(4):1024-1032. PubMed ID: 28580646 [TBL] [Abstract][Full Text] [Related]
160. How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review. Ramiro S; Smolen JS; Landewé R; Heijde DV; Gossec L Ann Rheum Dis; 2018 May; 77(5):782-783. PubMed ID: 28584188 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]